Vitamin D and Lupus Outcomes (11.21.2025)
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com.
Read Article
RNL 25 Replay: Spondyloarthritis
Enjoy these excerpts from the RNL 2025 meeting, and join us for RNL 2026 in Dallas, TX - registration is now open! Visit https://t.co/o78Pc8LPsQ for complete details.
https://t.co/OuVLKKbA6U https://t.co/zPiuSH47Fg
Dr. John Cush @RheumNow( View Tweet )
"Play the game for more than you can afford to lose... only then will you learn the game.”
- Winston Churchill
Dr. John Cush @RheumNow( View Tweet )
Did you miss RheumNow Live 2025? 👀
Don’t make the same mistake twice.
🔥 RNL 2026 Early Bird Registration is LIVE — now through Dec 1.
Where clinical science meets real-world rheum talk.
🎟️ https://t.co/zYYC2350tE https://t.co/uZUlqScSm5
Links:
Dr. John Cush @RheumNow( View Tweet )
Rheumatology Supply and Demand (2009 - 2024)
A retrospective review of US rheumatology manpower and training from 2009- ‘24 shows that US rheumatology training has become competitive, with an increasing surplus of applicants compared to available training positions. https://t.co/2yWZt8eeEJ
Dr. John Cush @RheumNow( View Tweet )
ACR Applauds Bipartisan Support for Prior Authorization Reform Bill
The ACR commended the more than 295 bipartisan, bicameral cosponsors of The Improving Seniors’ Timely Access to Care Act, which, if enacted, would reform the prior authorization process for Medicare Advantage https://t.co/n0MKkSqRwO
Dr. John Cush @RheumNow( View Tweet )
RheumNow Live 2026
Rheumatologists don’t just attend #RheumNowLive — they shape it.
Join the conversation that defines our field.
🕓 Early Bird registration open through 12/1
👉 https://t.co/zYYC2350tE
#RheumTwitter #Rheumatology #CME #RNL2026 #MedTwitter #HCPcommunity https://t.co/ejOB2WmOiv
Links:
Dr. John Cush @RheumNow( View Tweet )
Organ Involvement with Behçet’s
A review of patient data from the International AutoInflammatory Disease Alliance (AIDA) Network registry identifying those with mucocutaneous Behçet’s disease (BD) may progres to major organ involvement (MOI)m especially at later stages.
Read Article
A New Disease Activity Score for Antiphospholipid Syndrome?
EurekAlert!
APS is a systemic autoimmune disorder. It is characterised by the presence of antiphospholipid antibodies and a broad spectrum of clinical features, causing obstetric as well as thrombotic, microvascular and non-thrombotic (TMN) symptoms. These can range in severity, and people may have
Read Article
Seeking Musculoskeletal Care
A report entitled The Burden of Musculoskeletal Diseases in the United States (BMUS) report was published by the US Bone and Joint Decade (USBJD) with input from rheumatology, orthopedic surgery, physical medicine and rehabilitation regarding musculoskeletal care.
Read Article
Rheumatology Supply and Demand (2009 - 2024)
A retrospective review of US rheumatology manpower and training between 2009 and 2024 shows that US rheumatology training has become competitive with an increasing surplus of applicants compared to available training positions, which have also increased over time.
Read Article
RNL 25 Replay: Rheumatoid Arthritis
Enjoy these excerpts from the RNL 2025 meeting, and join us for RNL 2026 in Dallas, TX - registration is now open! Visit https://t.co/o78Pc8LPsQ for complete details
https://t.co/10AWx98UAk https://t.co/16FdwSu9he
Dr. John Cush @RheumNow( View Tweet )
ACR Applauds Bipartisan Support for Prior Authorization Reform Bill
ACR
The American College of Rheumatology (ACR) today commended the more than 295 bipartisan, bicameral cosponsors of The Improving Seniors’ Timely Access to Care Act, which, if enacted, would reform the prior authorization process for Medicare Advantage plans.
Read Article
Can EMR Treatment Suggestions Improve Decision Making?
In a new study, researchers from Northwestern University and the University of Sydney identified a “sweet spot” in clinical decision-making. By presenting just the right number of treatment alternatives in the EHR system, https://t.co/X0eHDIk3Uw
Dr. John Cush @RheumNow( View Tweet )
+ANA's are common in pregnancy. Study of 2159 Chinese 1st trimester pregnant women found ANAs positivity in 14.7 % (1:100 most common titer; speckled most common pattern). ANA+ assoc w/ smoking, age 30-34 yrs, multiparity, thyroid Dz & hypertension https://t.co/mRQGajVe3g https://t.co/DqE1KC4Kgo
Links:
Dr. John Cush @RheumNow( View Tweet )
Learning just got smarter.
Every week, RheumIQ challenges you with a quick quiz on current rheumatology updates.
💡 Educational
🎯 Evidence-based
🧠 Addictive (in a good way)
Try it now and level up your clinical knowledge: https://t.co/n6xlBFMPLI https://t.co/RHci93G46T
Dr. John Cush @RheumNow( View Tweet )
"The good physician treats the disease; the great physician treats the patient who has the disease." – Elizabeth Blackwell
Dr. John Cush @RheumNow( View Tweet )
Sjogren’s disease: two drugs with positive trials Sjogren’s disease: two drugs with positive trials
After several failures of therapies in Phase 3 trials of Sjogren’s disease (SjD) over many years, all hope is not lost! At #ACR25, not one but two drugs presented their efficacy https://t.co/tGwUrLMZEI
Dr. John Cush @RheumNow( View Tweet )
Tocilizumab Beats Methotrexate in GCA
Dr. Mike Putman reports on abstract 0891 (MEthotrexate versus TOcilizumab for treatment of Giant cell Arteritis (METOGiA trial): a multicenter, randomized, controlled trial), presented at the #ACR25.
https://t.co/IeCWZGupqR https://t.co/SCF1guorMs
Dr. John Cush @RheumNow( View Tweet )
Putting Steroid Tapering into Practice in SLE
Drs. Yuz Yusof and Ed Vital discuss abstract 1526 (Guidance For Corticosteroid Tapering In Patients With Systemic Lupus Erythematosus: Results From An International Delphi Consensus Project) presented at #ACR25. https://t.co/nqMyy3qNto
Dr. John Cush @RheumNow( View Tweet )
Treating During Pregnancy (11.14.2025)
Dr. Jack Cush reviews the journal articles, news and guidelines from this past week on RheumNow.com
Read Article
Day 2 Recap: #ACR25 Highlights
Join RheumNow Faculty Drs. David Liew, Antoni Chan, Mrinalini Dey, and Jack Cush as they discuss highlights and key takeaways from the Day 2 Recap.
https://t.co/aBxLuDhIMC https://t.co/q75eHf45Gt
Dr. John Cush @RheumNow( View Tweet )
Sjögren's disease RCTs: Has the Long Drought Ended?
At #ACR25, two late breaking abstracts have triggered hope for patients suffering from Sjögren's disease.
https://t.co/nNNx5sXzCz https://t.co/r9VBgyYgOC
Dr. John Cush @RheumNow( View Tweet )
PRED-SAFE: Shared Decision-Making Tool for Chronic Prednisone Use
Drs. Jiha Lee and Shivani Garg discuss abstract 1052 (“Prednisone… A Necessary Evil…” Developing an Evidence-Based Benefits vs. Harms Shared Decision-Making Tool (PRED-SAFE) to Support Decisions Around Chronic https://t.co/ZBH61Uzzc8
Dr. John Cush @RheumNow( View Tweet )
Learning just got smarter.
Every week, RheumIQ challenges you with a quick quiz on current rheumatology updates.
💡 Educational
🎯 Evidence-based
🧠 Addictive (in a good way)
Try it now and level up your clinical knowledge: https://t.co/oa2wxIRGZv https://t.co/wyZYdabM2G
Links:
Dr. John Cush @RheumNow( View Tweet )
Recent Blogs
